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OBJECTIVES To compare the significance of a specific feature of coronary atherosclerosis—coronary
calcium—in asymptomatic black and white subjects with coronary risk factors.
BACKGROUND The natural history and clinical evolution of coronary atherosclerosis differs between blacks
and whites. Differences in the underlying pathobiology of atherosclerosis may be one
determinant of the ethnic variability in the clinical manifestation of coronary atherosclerosis.
METHODS In 1,375 high-risk but asymptomatic subjects (93 blacks [6.8%] and 1,282 whites [93.2%])
with at least one risk factor but no prior evidence of coronary disease, we assessed coronary
risk factors, calculated Framingham risk of a coronary event and evaluated coronary calcium
with digital subtraction fluoroscopy. We then followed these subjects clinically for 70 6 13
months, noting the occurrence of the following coronary events: death due to coronary heart
disease (CHD); myocardial infarction (MI); angina pectoris; and performance of coronary
bypass or angioplasty.
RESULTS Risk factor profiles were similar in black and white subjects (6-year Framingham risk 15 6
7% in blacks, 14 6 8% in whites [NS]). Coronary calcium was present in 59.9% of white
subjects but only 35.5% of black subjects (p 5 0.0001). Nevertheless, after 70 months of
follow-up, more blacks than whites (22 blacks [23.7%] vs. 190 whites [14.8%]; p 5 0.04)
suffered one of the following end points: CHD death, MI, angina or revascularization. The
age, gender and coronary risk-adjusted odds ratio of black race for at least one event was 2.16
(95% CI 1.34 to 3.48).
CONCLUSIONS Despite having a lowered prevalence of coronary calcium than high risk whites, high risk
blacks suffer more CHD events. Coronary calcium therefore does not carry the same
pathobiologic significance in blacks that it does in whites, consistent with the concept that
there are specific racial differences in the natural history of CHD and its evolution into
clinically manifest events. (J Am Coll Cardiol 1999;34:787–94) © 1999 by the American
College of Cardiology
Blacks suffer an inordinately high degree of adverse cardio-
vascular events (1–3), posing an important but unsolved
public health dilemma. While both underutilization (4) and
diminished access to health care services (5) appear to
significantly contribute, there are persistent suggestions that
there may be ethnic differences in the pathobiology of
atherosclerosis that may affect the clinical expression of the
disease.
Ethnic differences in risk factors appear early in child-
hood (6,7) and may impact subsequent racial variation in
clinical expression of the underlying substrate. For example,
data from several sources indicate that smoking has a
disproportionately lethal effect on blacks (8–10). The Ath-
erosclerosis Research in Communities (ARIC) study (11)
and other reports (12–14) have implicated socioeconomic
status as a contributor to cardiovascular morbidity and
mortality. However, data from the Meharry-Hopkins Study
in black and white physicians, presumably of comparable
socioeconomic status, indicate that systolic blood pressure
has a higher adjusted odds ratio for coronary events in black
physicians but serum cholesterol is more deleterious in
white physicians (15). Recent 16 year follow-up data from
the Coronary Artery Surgery Study (CASS) indicate that
even after adjusting for all clinical and treatment variables,
black race was a strong predictor of mortality in both the
surgical and medical groups (8). Collectively, these data are
consistent with the concept that there are ethnic differences
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in the pathobiology of atherosclerosis that affect its eventual
clinical manifestations.
The pathobiologic substrates underlying these ethnic
differences are unknown, but recent studies suggest the
distinct possibility that coronary calcium—a specific and
widely prevalent feature of coronary plaque—does not carry
the same significance in blacks that it does in whites. For
example, black subjects have a lower incidence of coronary
calcification compared to whites, despite having a similar
risk factor profile (16,17) and thus a roughly comparable risk
of coronary heart disease (CHD) events. Furthermore, even
after adjusting for the effects of all known determinants of
coronary calcium (age, gender, and 1a,25(OH)2D3 [16,18])
as well as all other coronary risk factors, high risk asymp-
tomatic blacks still have less coronary calcium than high risk
asymptomatic whites (16). Based on available data on the
prognostic significance of coronary calcium (19–24), this
lesser amount of calcium in blacks should predict fewer
subsequent events.
On the contrary, we report that although blacks have a
lower prevalence of coronary calcium than whites, they
nevertheless suffer greater numbers of coronary events, even
after adjusting for the effects of risk factors. Therefore,
coronary calcium is of different pathobiologic significance in
black subjects with coronary risk factors compared to white
subjects with similar risk factors.
METHODS
Subjects. All subjects gave written informed consent to
voluntarily participate in this investigation and no subject
was required to pay for testing. The study received approval
from the Human Subjects Committee at our institution.
Subjects were excluded if they had history or electrocardio-
graphic evidence of a prior myocardial infarction (MI) or if
they answered affirmatively to the first and two other
questions from the following angina questionnaire: a) Do
you suffer from chest discomfort? b) Does it last less than 15
minutes? c) Does the pain come on when you exert yourself?
d) Is the pain relieved by rest or nitroglycerin? This
definition of angina is similar to that used by Diamond and
Forrester (25) and that used by the Framingham investiga-
tors (26).
A total of 1,461 subjects satisfied these enrollment
criteria. Eighty six subjects from ethnic groups other than
black or white (82 Asian Americans, 4 Native Americans)
were excluded from analysis in this report. The remaining
1,375 subjects were either black (n 5 93; 6.8%) or white
(n 5 1,282; 93.2%), were asymptomatic at the time of
coronary calcium assessment, underwent risk factor evalua-
tion at the time of coronary calcium screening, and were
followed prospectively thereafter by the South Bay Heart
Watch Clinic to determine coronary events. Details of
recruitment, selection and risk factor evaluation methodol-
ogy have been previously published (23,24,27).
Our cohort was, by design, high-risk but asymptomatic,
with no clinical or electrocardiographic (ECG) evidence of
CHD, but all had .8% risk of a coronary heart disease
event within six years, based on risk factor analysis and
calculations utilizing the Framingham risk algorithm
(26,28). All 1,375 subjects underwent evaluation of coro-
nary calcium using digital subtraction fluoroscopy
(23,24,27,29) and were evaluated annually thereafter.
Risk factor analysis. The following risk factors were as-
sessed for each subject at the time of digital fluoroscopic
coronary calcium assessment: age, gender, total serum cho-
lesterol, high-density lipoprotein (HDL) cholesterol, sys-
tolic blood pressure, body mass index, history of hyperten-
sion, history of diabetes mellitus, history of smoking, family
history of coronary heart disease, and left ventricular hyper-
trophy (LVH) by ECG (Romhilt-Estes LVH score) (Table
1). We also obtained information on current medication
usage (Table 2). Details of risk factor assessment method-
ology are reported elsewhere (23,24,27).
Ethnicity. Ethnicity was determined by a clinical research
nurse who questioned subjects regarding their ethnic ances-
try and classified each subject as African American, Asian
American, white, or Native American. Of the 1,461 subjects
Abbreviations and Acronyms
CHD 5 coronary heart disease
CI 5 confidence interval
ECG 5 electrocardiographic
HDL 5 high density lipoprotein
LVH 5 left ventricular hypertrophy
MI 5 myocardial infarction
OR 5 odds ratio
Table 1. Coronary Heart Disease Risk Factors and Ethnicity
Risk Factor Blacks Whites
p
Value
Age (yr) 60 6 8 64 6 8 0.0001
Male (%) 86 88 0.67
History of hypertension (%) 54 43 0.03
Systolic blood pressure
(mm Hg)
150 6 22 143 6 18 0.002
History of diabetes (%) 27 17 0.01
Total cholesterol (mg/dl) 246 6 47 241 6 49 0.32
High-density lipoprotein
cholesterol (mg/dl)
46 6 12 44 6 14 0.25
Currently smoking (%) 22 21 0.96
Any smoking history 77 73 0.30
Family history (%) 32 46 0.01
Left ventricular hypertrophy
by electrocardiogram (%)
8.6 5.9 0.30
Body mass index (kg/m2) 32 6 5 30 6 5 0.02
Six-year Framingham risk (%) 15 6 7 14 6 8 0.64
Entries are either mean values 6 1 SD or percentages. Comparisons use chi-square
or Student’s t test.
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enrolled, there were a total of 1,282 whites (87.7%), 93
blacks (6.4%), 82 Asian Americans (5.6%) and 4 Native
Americans (0.3%). The proportion of minority subjects
enrolled was roughly comparable to the ethnic compositions
of the communities from which these subjects originated
(17).
Digital subtraction fluoroscopy. We performed digital
fluoroscopy in all subjects in the 60° left anterior oblique
projection utilizing a Philips digital cinefluoroscopic x-ray
imaging system. Further details of the image acquisition
protocol have been reported elsewhere (17,23,24,27). Al-
though there are no published head-to-head comparisons of
digital fluoroscopy with the newer radiographic technology,
electron beam computed tomography, we expect that the
former technology will be somewhat less sensitive than the
latter. All fluoroscopic images were assessed for the presence
or absence of calcium in the distribution of each of the
coronary arteries by two observers (RCD and WT), both
blinded to risk factor information as well as to the other
observer’s interpretation. Interobserver differences in inter-
pretation occurred in 7.7% of cases and were resolved by the
two observers after review and consensus decision (30).
Follow-up. Subjects were assessed annually after enroll-
ment, risk factor assessment and coronary calcium fluoro-
scopy, and then followed for 70 6 13 months (successful
follow-up was obtained in over 98% of subjects). The mean
follow-up duration was 72 6 13 months and 70 6 13
months for blacks and whites, respectively (p 5 NS).
There were a total of six follow-up evaluations during the
70 6 13 month follow-up period. Of the 93 black subjects
in the cohort, 91 (97.8%) returned to the South Bay Heart
Watch Clinic for at least one visit. Of the 1,282 white
subjects, 1,248 (97.3%) returned to our clinic for at least one
visit. The first two annual follow-up evaluations occurred
principally in the South Bay Heart Watch Clinic, and the
remaining four evaluations were largely by telephone.
At each follow-up visit evaluation, we assessed CHD
status using review of medical records and transcriptions of
conversations with families for infarctions, revasculariza-
tions and CHD deaths and the responses to the same angina
questionnaire administered as on the initial visit (23,24,27).
Three cardiologists met quarterly to decide by majority rule
on all cases for which at least one member had diagnosed an
MI (using criteria specified below, and previously reported
[23,24,27]). Subjects unable or unwilling to return to the
clinic were contacted by telephone by a research nurse and
were either visited in their home by staff personnel or were
mailed a questionnaire to obtain information on angina and
hospital admissions.
Medical records were obtained for all but two hospital
admissions (one black and one white subject). For subjects
who died outside of a hospital, we obtained transcriptions of
conversations with next of kin regarding circumstances and
symptoms preceding death. Coronary heart disease end
points were: 1) angina pectoris; 2) acute MI; 3) myocardial
revascularization; and 4) CHD death. Evaluation of medical
records to determine CHD end points was performed by a
committee of three board-certified cardiologists without
knowledge of coronary calcium results, ethnic origin or risk
factor data. Evaluations by committee members were per-
formed separately, and the entire committee would then
meet periodically to decide by majority rule only those cases
where there was not unanimous agreement among commit-
tee members whether or not an event had occurred. At
follow-up, angina pectoris was defined as present by a score
of 4 on the angina questionnaire that had been administered
at screening. Thus, an increase in angina score from baseline
of at least two was required in order to achieve this
endpoint.
Coronary heart disease death was determined by the
committee without knowledge of coronary calcium, ethnic-
ity or other data by review of medical records (23,24,27).
The committee also attributed each death either to CHD or
non-CHD causes.
Statistical analysis. Two-tailed Fisher’s exact test was used
to evaluate ethnic differences in coronary calcification and
CHD events. Either two-tailed Fisher’s exact test or Stu-
dent’s t test was performed to compare differences in risk
factors between ethnic groups. These tests were utilized to
provide the most conservative method possible to test our
hypotheses. Logistic regression was performed to evaluate
the influence of risk factors and ethnicity on the occurrence
of CHD events. Kaplan-Meier curves were compared using
the Wilcoxon test. An alpha value ,0.05 was considered
significant.
RESULTS
Risk factors. Coronary heart disease risk factor data com-
paring black and white subjects are depicted in Table 1.
Black subjects had a significantly higher systolic blood
pressure (p 5 0.002) and body mass index (p 5 0.02), a
higher incidence of diabetes mellitus (p 5 0.01) and more
frequent history of hypertension (p 5 0.03) compared to
white subjects. However, white subjects were significantly
older (p 5 0.0001) and had a greater incidence of positive
family history of CHD compared to black subjects (p 5
0.01). There were no significant ethnic differences in gen-
der, total cholesterol, HDL cholesterol, history of smoking,
current smoking status, LVH by ECG, or calculated
Framingham risk of a coronary event in six years (Table 1).
Table 2. Medication Use by Race
Medication Blacks Whites p*
Aspirin† 33% 43% 0.16
Beta-blocking agents 16% 9% 0.06
Other antihypertensive agents 58% 46% 0.06
Cholesterol-lowering medications 20% 26% 0.16
†Aspirin taken at least four times per week. *Two-tailed Fischer exact text. Entries are
percentages. Comparisons use two-tailed chi-square.
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There were also no significant ethnic differences in medi-
cation usage (Table 2), although there were trends towards
more use of both beta blockers and other antihypertensive
agents in black subjects (p 5 0.06 for both comparisons).
Coronary calcium prevalence. The prevalence of any cor-
onary calcium was 58.2% (n 5 801) in the entire cohort.
The prevalence of coronary calcium in black subjects was
35.5% (n 5 33) and in white subjects was 59.9% (n 5 768);
this difference was highly significant (p , 0.0001).
Distribution of coronary calcium. Of the entire cohort, a
total of 409 subjects (29.7%) had calcium in one coronary
artery, 239 subjects (17.4%) had calcium in two coronary
arteries and 153 subjects (11.1%) had calcium in all three
coronary arteries.
Racial differences in the topographic distributions of
coronary calcium are summarized in Table 3. Of the black
cohort, 20 subjects (21.5%) had calcium in one coronary
artery, 8 subjects (8.6%) had calcium in two coronary
arteries and 5 (5.4%) had calcium in all three coronary
arteries. Of the white cohort, 389 (30.3%) had calcium in
the distribution of only one coronary vessel, 231 subjects
(18.0%) had calcium in two coronary arteries, while 148
(11.5%) had calcium in all three coronary vessels.
Determinants of coronary calcium. Multivariate logistic
regression analysis demonstrated black race to be a signifi-
cant, independent and inverse predictor of the presence of
coronary calcium (odds ratio [OR] 0.47; 95% confidence
interval [CI], 0.29, 0.75). Age, male gender, smoking status,
family history, diabetes mellitus, LVH, and serum total
cholesterol were significant independent predictors of the
presence of coronary calcium by digital fluoroscopy. These
results are summarized in Table 4, along with the corre-
sponding ORs and 95% CIs.
Coronary heart disease events. Despite having a lower
prevalence of coronary calcium, more black subjects than
white subjects suffered a CHD endpoint during the 70
month follow-up period. This difference was highly signif-
icant (p 5 0.001), and is depicted in Figure 1, which shows
event-free survival for blacks and whites as a function of
time.
Table 5 shows ethnic differences in the occurrence of end
points during the follow-up period. The occurrence of any
end point (CHD death, nonfatal MI, new onset angina, or
performance of a revascularization procedure) was more
frequent in black subjects than in white subjects (22 blacks
[23.7%]; 190 whites [14.8%]; p 5 0.04). Blacks were also
significantly more likely to suffer either CHD death, MI or
new onset angina compared to white subjects (20 blacks
[21.5%]; 162 whites [12.6%]; p 5 0.03).
Figure 1. Kaplan-Meier event-free survival curves in black and
white subjects during the 70 month follow-up period. Black
subjects were significantly more likely than white subjects to suffer
a coronary event (p 5 0.001; Wilcoxon test).
Table 3. Comparison of the Topological Distributions of
Coronary Calcium by Race
Number of
Calcified Arteries
All Blacks
(n 5 93)
All Whites
(n 5 1,282)
None 64.5% 40.2%
One 21.5% 30.3%
Two 8.6% 18.0%
Three 5.4% 11.5%
Blacks with
Ca11 (n 5 33)
Whites with
Ca11 (n 5 768)
One 60.6% 50.6%
Two 24.2% 30.1%
Three 15.2% 19.3%
In the top half of the table, numbers shown in the second column (blacks) represent
percentages of the black cohort (n 5 93). Numbers in the third column (whites)
represent percentages of the white cohort (n 5 1,282). In the bottom half of the table,
the proportions shown in the second column are percentages of the black cohort who
had at least some detectable calcium (n 5 33). The percentages in the third column
are percentages of those white subjects who had some detectable calcium (n 5 768).
Table 4. Independent Predictors of the Presence of Any
Coronary Calcium
Variable
Odds
Ratio
95%
CI
Age (per decade) 2.57 2.12, 3.12
Smoking 1.62 1.20, 2.20
Hypertension 1.46 1.15, 1.86
Family history 1.24 1.10, 1.39
Left ventricular hypertrophy by
electrocardiogram
1.79 1.05, 3.05
Male gender 1.26 1.03, 1.53
Diabetes 1.19 1.01, 1.41
Total cholesterol (per 10 mg/dl) 1.03 1.01, 1.06
High-density lipoprotein cholesterol
(per 10 mg/dl)
0.96 0.88, 1.05
Black race 0.47 0.29, 0.75
Body mass index (per 10 kg/m2) 0.90 0.70, 1.17
Black race was a significant inverse predictor of coronary calcium presence. Age,
smoking history, hypertension, family history, LVH, male gender, diabetes and total
cholesterol were all significant independent predictors of coronary calcium.
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There were a total of 126 deaths in the entire cohort (11
[11.8%] blacks and 115 [9.0%] whites; p 5 0.35). The
majority (85 [67.5%]) of deaths were not attributed to CHD
by the Adjudication Committee. In all instances where the
Adjudication Committee decided a death was due to CHD,
the decision was based upon the occurrence of either a
sudden unexpected death or an MI death. There were no
autopsy-determined CHD deaths.
There were more MIs (either fatal or nonfatal) in black
subjects compared to white subjects (9 blacks [9.7%]; 62
whites [4.8%]; p 5 0.05). Black subjects were also more
likely to suffer new onset angina (14 blacks [15.1%]; 97
whites [7.6%]; p 5 0.02). There was also a trend towards
more hard events (CHD death or MI) in black subjects
compared to whites, but the difference did not reach
statistical significance (11 blacks [11.8%]; 86 whites [6.7%];
p 5 0.09). The performance of revascularization procedures
(percutaneous coronary angioplasty or coronary bypass) did
not differ between the races (4 blacks [4.3%]; 76 whites
[5.9%]; p 5 0.65). There was also no significant ethnic
difference in the occurrence of CHD deaths during the
follow-up period (4 blacks [4.3%]; 37 whites [2.9%]; p 5
0.35).
Table 6 shows the relationship between calcification and
end points (CHD death, MI, angina, or revascularization)
in blacks and whites. Multivariate logistic regression anal-
ysis using the occurrence of any of these end points as the
dependent variable revealed that black race was a significant
and independent predictor of the occurrence of a CHD end
point (OR 2.16; 95% CI 1.34, 3.48) (Table 7). Additional
significant and independent predictors of a CHD event
included the presence of LVH by ECG (OR 2.18; 95% CI
1.35, 3.52), a history of diabetes mellitus (OR 1.21; 95% CI
1.02, 1.43;), the number of calcified coronary vessels (OR
1.16; 95% CI 1.01, 1.33;), a history of hypertension (OR
1.34; 95% CI 1.02, 1.76) and total serum cholesterol (OR
1.03; 95% CI 1.00, 1.06). High-density lipoprotein choles-
terol was a significant inverse predictor of a coronary
endpoint (OR 0.84; 95% CI 0.75, 0.93). Age, history of
smoking, gender and family history of CHD were not
significant independent predictors of a CHD event.
DISCUSSION
Coronary calcium indicates concomitant atherosclerotic dis-
ease (31), and prospective studies have demonstrated that
subjects with coronary calcium have a higher risk of subse-
quent coronary events compared to similar subjects without
coronary calcium (19–24). However, we report here that in
a cohort of asymptomatic subjects with coronary risk factors,
coronary calcium detected with digital fluoroscopy was less
prevalent in blacks than in whites, yet more blacks than
whites suffered coronary events during a 70 month
follow-up period. These results indicate that there are
differences in a measurable pathobiologic characteristic of
coronary lesions—calcific deposits—detected in vivo, in
Table 5. Coronary Events and Ethnic Origin at 70 Months of
Follow-up
Event Blacks* Whites† p Value
New-onset angina 15.1 7.6 0.02
MI 9.7 4.8 0.05
CHD death 4.3 2.9 0.35
Revascularization 4.3 5.9 0.65
Total deaths 11.8 9.0 0.35
CHD death or MI 11.8 6.7 0.09
CHD death, MI or angina 21.5 12.6 0.03
CHD death, MI angina,
revascularization
23.7 14.8 0.04
*Entries represent percentages of black cohort (n 5 93). †Entries represent percent-
ages of white cohort (n 5 1,282).
Blacks were significantly more likely to suffer new-onset angina pectoris than white
subjects. Black subjects were also more likely to suffer one of the end points of CHD
death, infarction or angina. In addition, blacks more frequently suffered any end point.
There was a trend toward more hard coronary events (CHD death or infarction) in
black subjects, but this trend did not reach statistical significance. There were no
ethnic differences in CHD death rates, frequency of coronary revascularization
procedures or total death rates from any cause.
CHD 5 coronary heart disease; MI 5 myocardial infarction.
Table 6. Race, Calcification and Coronary End Points
Events No Events
Blacks
Calcium present 10 (45.5%) 23 (32.4%)
Calcium absent 12 (54.5%) 48 (67.7%)
Whites
Calcium present 138 (72.6%) 630 (57.7%)
Calcium absent 52 (27.4%) 462 (42.3%)
Numbers in parentheses indicate proportion of initial cohort for each race (blacks, n 5
93; whites, n 5 1,282).
Table 7. Independent Predictors of Any Coronary Event by
Multivariate Logistic Regression, Along With Odds Ratios and
95% Confidence Intervals
Variable
Odds
Ratio
95%
CI
Black race 2.16 1.34, 3.48
Left ventricular hypertrophy 2.18 1.35, 3.52
History of diabetes 1.21 1.02, 1.43
Number of calcified vessels 1.16 1.01, 1.33
History of hypertension 1.34 1.02, 1.76
Total cholesterol (per 10 mg/dl) 1.03 1.00, 1.06
Family history of coronary heart disease 1.13 0.99, 1.29
Male gender 1.01 0.81, 1.25
Age (per decade) 1.09 0.89, 1.34
Smoking history 1.01 0.72, 1.42
High-density lipoprotein cholesterol
(per 10 mg/dl)
0.84 0.75, 0.93
Black race was an independent predictor of a subsequent coronary event. Other
independent predictors of a coronary event included left ventricular hypertrophy,
history of diabetes mellitus, number of calcified coronary arteries, history of hyper-
tension and total cholesterol levels. High-density lipoprotein cholesterol was a
significant independent and inverse predictor of a coronary event.
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two ethnic groups destined to suffer similar numbers of
adverse outcomes.
Potential Explanations for Ethnic Differences
1. Differences in prevalence of atherosclerosis. It is pos-
sible that our black subjects had a lesser prevalence of
coronary calcium because they had less coronary atheroscle-
rosis than our white subjects. There are conflicting data on
the prevalence and severity of coronary atherosclerosis in
blacks and whites. Autopsy studies prior to the 1980s
(32,33) have shown that blacks have less severe coronary
atherosclerosis than whites, but more recent post-mortem
data indicate that these differences are not significant (34).
However, pathologic studies also have shown that blacks
have less atherosclerotic calcium than whites (35,36). For
example, Strong and McGill have reported that aortic
lesions in whites were calcified 1.6 times more frequently
than similar lesions in blacks (36). Consistent with these
findings, our data also suggest that blacks have a lower
frequency and severity of coronary calcium, despite similar
or even greater risk of CHD events.
The National Institutes of Health has planned a large,
multiethnic investigation to determine the interaction of
coronary calcification and ethnicity in the prediction of
CHD events (37). This study should more fully define the
relationship of calcium quantity to CHD events in several
ethnic groups.
2. Differences in calcium metabolism. Ethnic differences
in bone metabolism have been previously reported; for
example, despite a lower calcium intake (38), blacks have
greater bone mass (39) and a lower incidence of osteoporosis
and hip fractures (40) compared to whites. Several
studies (41–43) have demonstrated racial differences in
endocrine factors that affect bone metabolism and that,
given the similarities between atherosclerotic calcification
and osteogenesis (44,45), could affect mineralization at
lesion sites. We have recently shown that serum levels of
1a,25(OH)2D3 are inversely related to calcium mass
(16,18), that blacks have higher levels of 1,25(OH)2D3, but
these differences are not sufficient to fully account for the
observed racial differences in coronary calcium (16). It is
therefore conceivable that ethnic differences in endocrine
mechanisms in addition to vitamin D metabolism may be
contributing factors. However, these possibilities, while
perhaps explaining racial differences in the amount of
coronary calcium, do not explain why blacks have more
events than whites.
3. Myocardial Mass. Recent studies suggest that myocar-
dial mass may be a more important factor leading to sudden
cardiac death in blacks than in whites (15,46). This rela-
tionship might be pertinent to our findings. Although both
a history of hypertension and LVH by ECG were signifi-
cant independent predictors of events in the entire cohort,
we did not find a more significant independent association
between LVH (by ECG) and coronary events in blacks,
perhaps due to inadequate power in our study.
4. Differing importance of risk factors. Population-based
epidemiologic studies indicate that predictors of CHD
mortality were similar in blacks and whites except that
cigarette smoking carried a greater risk for blacks, while
serum cholesterol carried a greater risk in whites (1,9). Data
from the Meharry-Hopkins Study which prospectively eval-
uated risk factors in black and white physicians suggest that
systolic blood pressure is a relatively more important pre-
dictor of CHD events in black compared to white physi-
cians, but serum cholesterol is more important in white
physicians (15). Although Framingham risk in our black
and white cohorts was identical, risk factor differences
(Table 1 and Results) could have accounted for some of the
observed differences in CHD events.
Blacks with symptomatic CHD have a poorer prognosis
compared to whites (3,47,48), which at least in part appears
to be due to limited access of blacks to care (49) and
decreased utilization of revascularization procedures by
blacks (4,6,50,51). Since our subjects were asymptomatic
and had no evidence of coronary disease at enrollment and
since rates of revascularization were similar, any effects of
ethnic differences in access to care on our results would
probably have been minimal, but cannot be excluded.
Study limitations. Though ours was a population based
study of the South Bay suburbs of Los Angeles, there is the
possibility that differing referral patterns between whites
and blacks might have influenced the results. Education and
socioeconomic status have been shown to have an effect on
CHD outcomes. These were not controlled for in our study.
Our study has limited power for determining the predictive
accuracy of coronary calcium in blacks. There were few
black women in our sample and for this and other reasons,
our results may not be applicable to other populations.
Therefore, despite the fact that this was not significant in
our cohort (Table 6), larger multi-ethnic sample sizes may
clarify these issues (37).
Conclusion. Our results demonstrate that black subjects
with coronary risk factors have a lower prevalence of
coronary calcium than similar white subjects, but have at
least as many CHD events on follow-up. Our black sample
was too small to determine if coronary calcium is predictive
of outcomes in blacks. Further investigations into ethnic
differences in the mechanistic determinants of coronary
heart disease events are needed and are underway. It is
hoped that such data may result in improved treatment to
minimize the morbidity and mortality of CHD, particularly
in blacks.
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